CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project develops a computer-based method to enhance the effectiveness of drug repurposing trials. By simulating disease mechanisms, it aims to streamline the identification of potential treatments and validate them through targeted clinical trials.
Our programme will develop an innovative in-silico based approach to improve the efficacy and precision of drug repurposing trials.
We have chosen drug repurposing as it has the shortest time for clinical validation and translation.
Validation of all putatively de novo discovered drug repositionings within the time-frame of this programme would be unrealistic.
To improve efficacy and precision, and to adopt our computer simulation parameters and models, we choose a systems medicine based in-sili…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Denmark, Odense M
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, Newcastle Upon Tyne
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Essen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Hannover
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 topics.
Guests see up to 5 keywords.
